Breast cancer can be classified into several molecular subtypes, including hormone receptor-positive (ER+/PR+), human epidermal growth factor receptor 2-positive (HER2+), and triple-negative breast cancer (TNBC). This evidence concerns the gene ERBB2 and triple-negative breast carcinoma.